12 Ways to Improve Adherence
Specialty therapies face unique challenges surrounding patient safety, access to testing, mobility, and delays. Recent advancement of mobile ECGs help overcome these challenges, allowing patients to test within the privacy and convenience of their own home.
Leveraging AliveCor’s KardiaMobile 6L technology, IQVIA In Home Clinical Solutions pioneered a program among breast cancer patients that aimed to alleviate common pain points associated with ECG testing required for treatment.
The patients were provided a less invasive device which made it easier for them to take their own ECG readings. The program eliminated the need for the patients to travel to an office, significantly increasing the group’s adherence to treatment.
Key Takeaways
- KardiaMobile 6L uniquely addresses challenges surrounding speciality therapies
- The device offers a less invasive alternative to traditional 12-lead systems, mitigating additional and unnecessary pain points for cancer patients
- Remote ECG monitoring can improve patient adherence to treatment
In The News
12 Ways to Improve Adherence
PM360online.com | With treatment plans that require frequent ECG testing, patients with breast cancer are faced with even more challenges. Leveraging KardiaMobile® 6L, an IQVIA program alleviated the pains associated with traditional 12-lead systems.
At-Home Clinical Trials Are the Future
StatNews.com | Hybrid and decentralized clinical trials are rapidly advancing. To ensure DCT success, mobile digital health technologies, like portable ECGs, are proving more necessary than ever.
Remote Monitoring Boosts Decentralized Trials
PharmExec.com | Decentralized trials are known to have positive effects, but sponsors have concerns about how to monitor patients well. Remote patient monitoring (RPM) solutions, like those from AliveCor, are changing this paradigm. The benefits that decentralized trials offer patients and sponsors are evident. Yet, decentralized trials are still lacking.